Cipla Limited

Industry

  • Pharmaceuticals
    • Vaccines
    • Nutraceuticals
    • Drug Delivery
    • Generic Drugs
  • Services
    • Consulting Services
  • Biotechnology
    • Drug Discovery Technologies
      • Molecular Diversity
        • Natural Products
  • Contract Research Organization-CRO
  • Medical Devices

Other Names/Subsidiaries

  • Cipla Gulf FZ LLC
  • Cipla Technologies LLC
  • InvaGen Pharmaceuticals Inc.
  • Mirren Pty, Ltd.
See more in Biomedtracker

Latest on Cipla Limited

Scrip

Asia Deal Watch: Dr. Reddy’s Gets Regional Rights To Pair Of Bio-Thera Biosimilars

 
• By Joseph Haas, Jung Won Shin, and Lisa Takagi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Dr. Reddy’s Acquires Rights From

Scrip

Mounjaro In India: Price Differential, Window Of Opportunity

 
• By Anju Ghangurde

Eli Lilly’s blockbuster obesity and type 2 diabetes therapy, Mounjaro (tirzepatide) has made its India debut throwing down the gauntlet to rival Novo Nordisk, currently in the wings with Wegovy (injec

Generics Bulletin

Cipla Becomes Formosa’s Latest Clobetasol Partner With 11-Country Deal

 
• By Dean Rudge

Cipla has welcomed the firm’s first multi-regional licensing agreement in ophthalmology, after striking an exclusive licensing agreement bringing onboard Formosa Pharmaceuticals’ clobetasol propionate

Scrip

India Pharma Chiefs On Future Manufacturing Networks And Specter Of Tariffs

 
• By Anju Ghangurde

US President Donald Trump’s stance on reciprocal tariffs and policy efforts towards reshoring continue to make countries nervous and CEOs of India Pharma Inc, at a recent event, weighed in, signalli